A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)

Condition:   Acute Intermittent PorphyriaInterventions:   Drug: ALN-AS1;   Drug: Sterile Normal Saline (0.9% NaCl)Sponsor:   Alnylam PharmaceuticalsRecruiting - verified May 2015

Source: ClinicalTrials.gov - May 19, 2015 Category: Research Source Type: clinical trials